EX-23.1 4 exhibit231gtconsent.htm EXHIBIT 23.1 Exhibit 23.1 GT Consent


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We have issued our reports dated March 2, 2015 with respect to the consolidated financial statements and internal control over financial reporting included in the Annual Report on Form 10-K for the year ended December 31, 2014 of Caladrius Biosciences, Inc. (formerly NeoStem, Inc.), which are incorporated by reference in this Registration Statement. We consent to the incorporation by reference of the aforementioned reports in the Registration Statement, and to the use of our name as it appears under the caption “Experts.”


/s/ Grant Thornton LLP

New York, New York
August 6, 2015